Drug Profile
Ranibizumab biosimilar - Kidswell Bio/Senju Pharmaceutical
Alternative Names: GBS-007; OT-701; Ranibizumab-BS; SJP-0133Latest Information Update: 03 Jan 2022
Price :
$50
*
At a glance
- Originator Gene Techno Science; Senju Pharmaceutical
- Developer Kidswell Bio; Senju Pharmaceutical
- Class Eye disorder therapies; Immunoglobulin fragments; Monoclonal antibodies
- Mechanism of Action Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Age-related macular degeneration